Left Main Percutaneous Coronary Intervention Registry in Istanbul Medipol University Hospital
Comprehensive Registry of Left Main Coronary Artery Percutaneous Coronary Intervention Outcomes at Istanbul Medipol University Hospital
1 other identifier
observational
3,620
1 country
1
Brief Summary
This hospital-based registry study at Istanbul Medipol University Hospital focuses on documenting and analyzing the clinical and demographic characteristics, procedural-related aspects, and both short and long-term outcomes of patients undergoing left main coronary artery percutaneous coronary intervention (PCI). The study aims to identify predictors for adverse clinical outcomes in patients treated for left main coronary artery disease.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for all trials
Started Jun 2018
Longer than P75 for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
June 1, 2018
CompletedPrimary Completion
Last participant's last visit for primary outcome
December 31, 2022
CompletedStudy Completion
Last participant's last visit for all outcomes
December 31, 2023
CompletedFirst Submitted
Initial submission to the registry
February 8, 2024
CompletedFirst Posted
Study publicly available on registry
February 16, 2024
CompletedFebruary 16, 2024
February 1, 2024
4.6 years
February 8, 2024
February 15, 2024
Conditions
Outcome Measures
Primary Outcomes (1)
Incidence of Major Adverse Cardiac Events (MACE) within One Year Following Left Main Coronary Artery PCI
The primary outcome measure will be the incidence of major adverse cardiac events (MACE) within one year post-procedure in patients undergoing left main coronary artery PCI. MACE is defined as a composite of clinically significant endpoints including all-cause mortality, non-fatal myocardial infarction, non-fatal stroke, and any revascularization procedures required after the initial PCI.
up to 1 month, 3 months, 1 year
Secondary Outcomes (4)
Ischemia-Driven Target Vessel Revascularization (ID-TVR) Ischemia-Driven Target Vessel Revascularization (ID-TVR)
1 year
Procedure-Related Complications Within 30 Days of PCI
1 month
Health-Related Quality of Life (HRQoL) Scores One Year After PCI
1 year
Rate of stent thrombosis
1 month, 3 months, 1 year
Interventions
balloon angioplasty, stent implantation, atherectomy, intravascular ultrasound.
Eligibility Criteria
All patients performing any PCI procedure(s) in given timeframe will be included in this registry
You may qualify if:
- All patients undergoing any PCI procedure(s) in given timeframe will be included in this registry
You may not qualify if:
- Patients with no informed consent
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Istanbul Medipol University
Istanbul, Turkey (Türkiye)
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- PROSPECTIVE
- Target Duration
- 1 Year
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Prof Dr Ozgur Ulas Ozcan
Study Record Dates
First Submitted
February 8, 2024
First Posted
February 16, 2024
Study Start
June 1, 2018
Primary Completion
December 31, 2022
Study Completion
December 31, 2023
Last Updated
February 16, 2024
Record last verified: 2024-02